Avalign Technologies, a portfolio company of Arlington Capital Partners, has completed the acquisitions of Thortex and Millennium Surgical.
 
Thortex is a leading provider of proprietary porous coatings and metal injection molding as well precision manufacturing solutions to the medical device market. Thortex is one of the only companies in the world able to provide porous coating solutions for titanium and cobalt-chrome orthopedic implants. In addition, Thortex provides a full suite of manufacturing and engineering technologies including metal injection molding, CNC machining, finishing, and assembly to medical device OEMs.
 
Millennium is a provider of specialty surgical instruments focused on delivering difficult-to-find instruments utilizing innovative, e-cataloging, web-based marketing tools, and technical sales support. Millennium offers more than 17,000 branded SKUs across a variety of clinical areas including neurosurgery, ophthalmics and orthopedics to a diverse array of hospital and ambulatory surgical center customers.
 
Matt Altman, a Managing Partner at Arlington Capital said, “The incorporation of Thortex and Millennium into the Avalign platform adds new and proprietary capabilities which enhance Avalign’s strategic position in the marketplace. The increased scale and breadth of services and technologies provided by these acquisitions will accrue to the benefit of Avalign’s customers and bolster Avalign’s already impressive growth.”
 
“Thortex and Millennium nicely complement and expand the manufacturing technologies and services that Avalign offers and provide us with the ability to continue gaining share with our customers,” said Forrest Whittaker, CEO of Avalign Technologies. “We are excited to welcome the Thortex and Millennium teams to the Avalign family, and thankful for Arlington’s support in consummating these highly strategic acquisitions.”
 
Malcolm Little, a Principal at Arlington Capital, added: “The proprietary technologies developed by both Thortex and Millennium represent truly unique offerings in the market. We are pleased to complete these acquisitions and continue to pursue additional opportunities to strategically scale our business.”